1. Home
  2. SILO vs YOSH Comparison

SILO vs YOSH Comparison

Compare SILO & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • YOSH
  • Stock Information
  • Founded
  • SILO 2010
  • YOSH 2016
  • Country
  • SILO United States
  • YOSH United States
  • Employees
  • SILO N/A
  • YOSH N/A
  • Industry
  • SILO Apparel
  • YOSH Restaurants
  • Sector
  • SILO Consumer Discretionary
  • YOSH Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • SILO 4.5M
  • YOSH 23.7M
  • IPO Year
  • SILO N/A
  • YOSH 2022
  • Fundamental
  • Price
  • SILO $0.60
  • YOSH N/A
  • Analyst Decision
  • SILO
  • YOSH
  • Analyst Count
  • SILO 0
  • YOSH 0
  • Target Price
  • SILO N/A
  • YOSH N/A
  • AVG Volume (30 Days)
  • SILO 1.6M
  • YOSH 5.6K
  • Earning Date
  • SILO 08-12-2025
  • YOSH 08-18-2025
  • Dividend Yield
  • SILO N/A
  • YOSH N/A
  • EPS Growth
  • SILO N/A
  • YOSH N/A
  • EPS
  • SILO N/A
  • YOSH N/A
  • Revenue
  • SILO $72,102.00
  • YOSH $13,539,317.00
  • Revenue This Year
  • SILO $1.86
  • YOSH N/A
  • Revenue Next Year
  • SILO N/A
  • YOSH N/A
  • P/E Ratio
  • SILO N/A
  • YOSH N/A
  • Revenue Growth
  • SILO N/A
  • YOSH 41.82
  • 52 Week Low
  • SILO $0.41
  • YOSH $2.71
  • 52 Week High
  • SILO $4.50
  • YOSH $22.50
  • Technical
  • Relative Strength Index (RSI)
  • SILO 48.87
  • YOSH 34.47
  • Support Level
  • SILO $0.60
  • YOSH $9.19
  • Resistance Level
  • SILO $0.66
  • YOSH $10.00
  • Average True Range (ATR)
  • SILO 0.04
  • YOSH 0.76
  • MACD
  • SILO 0.01
  • YOSH -0.16
  • Stochastic Oscillator
  • SILO 55.10
  • YOSH 14.44

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: